GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (OTCPK:SNNUF) » Definitions » Price-to-Free-Cash-Flow

Smith & Nephew (Smith & Nephew) Price-to-Free-Cash-Flow

: 58.36 (As of Today)
View and export this data going back to 2009. Start your Free Trial

As of today (2024-04-19), Smith & Nephew's share price is $12.08. Smith & Nephew's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.21. Hence, Smith & Nephew's Price-to-Free-Cash-Flow Ratio for today is 58.36.

The historical rank and industry rank for Smith & Nephew's Price-to-Free-Cash-Flow or its related term are showing as below:

SNNUF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.78   Med: 29.73   Max: 127.62
Current: 60.06

During the past 13 years, Smith & Nephew's highest Price-to-Free-Cash-Flow Ratio was 127.62. The lowest was 16.78. And the median was 29.73.

SNNUF's Price-to-Free-Cash-Flow is ranked worse than
75.37% of 337 companies
in the Medical Devices & Instruments industry
Industry Median: 31.21 vs SNNUF: 60.06

Smith & Nephew's Free Cash Flow per Share for the six months ended in Dec. 2023 was $0.27. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.21.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Smith & Nephew was 59.20% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -26.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -27.90% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -6.50% per year.

During the past 13 years, Smith & Nephew's highest 3-Year average Free Cash Flow per Share Growth Rate was 97.20% per year. The lowest was -46.20% per year. And the median was 4.90% per year.


Smith & Nephew Price-to-Free-Cash-Flow Historical Data

The historical data trend for Smith & Nephew's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.72 36.21 32.18 107.72 65.76

Smith & Nephew Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.18 - 107.72 - 65.76

Competitive Comparison

For the Medical Devices subindustry, Smith & Nephew's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smith & Nephew Price-to-Free-Cash-Flow Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Price-to-Free-Cash-Flow falls into.



Smith & Nephew Price-to-Free-Cash-Flow Calculation

Smith & Nephew's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=12.08/0.207
=58.36

Smith & Nephew's Share Price of today is $12.08.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Smith & Nephew's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.21.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Smith & Nephew  (OTCPK:SNNUF) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Smith & Nephew Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Smith & Nephew (Smith & Nephew) Business Description

Traded in Other Exchanges
Address
Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Smith & Nephew (Smith & Nephew) Headlines

From GuruFocus

Smith+Nephew acquires novel cementless partial knee system

By PRNewswire PRNewswire 01-19-2022

Smith & Nephew: A Medical Equipment Opportunity

By The City Letter 08-09-2022